Blood Reviews
Volume 22, Issue 2 , Pages 53-63 , March 2008

Advances in the allogeneic transplantation for thalassemia

  • Guido Lucarelli

      Affiliations

    • Director, International Centre for Transplantation in Thalassemia and Sickle Cell Anemia, Mediterranean Institute of Hematology, Rome 00133, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 06 20661301; fax: +39 06 20661302.
    • ,
  • Javid Gaziev

      Affiliations

    • Senior Hematologist, International Centre for Transplantation in Thalassemia and Sickle Cell Anemia, Mediterranean Institute of Hematology, Rome 00133, Italy
    • Tel.: +39 06 20661307; fax: +39 06 20661302.

References 

  1. Weatheral DJ, Clegg JB. The Thalassemia Syndromes. 4th ed.. Oxford: Blackwell Science; 2001;
  2. Modell B, Khan M, Darlison M, et al. A national register for surveillance of inherited disorders: b thalassaemia in the United Kingdom. Bull World Health Organ. 2001;79:1006–1013
  3. Piga A, Longo F, Consolati A. Mortality and morbidity in thalassemia with conventional treatment. Bone Marrow Transplant. 1977;19(Suppl. 2):11–13
  4. Borgna- Pignatti C, Rugolotto S, DeStefano P, et al. Survival and complications in patients with thalassemia major treated with transfusions and deferrioxamine. Haematologica. 2004;89:1187–1193
  5. Modell B, Khan M, Darlison M. Survival in beta-thalassemia major in the UK: data from the UK Thalassemia Register. Lancet. 2000;355:2051–2052
  6. Pavlec I, Papayannopoulou T, Maury C, Meyer F. A human beta-globin gene fused to the human beta globin locus control region is expressed at high levels in erythroid cells of mice engrafted with retrovirus-transduced hematopoietic stem cells. Blood. 1993;81:1384–1392
  7. May C, Rivella S, Callegari J, et al. Therapeutic haemoglobin synthesis in beta –thalassemic mice expressing lentovirus-encoded human beta-globin. Nature. 2000;406:82–86
  8. Malik P, Arumugam PI. Gene therapy for β-thalassemia. Hematology. 2005;45–50
  9. Baum C, Dullmann J, Li Z, et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood. 2003;101:2099–2114
  10. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassaemia. Lancet. 1982;ii:227–229
  11. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with advanced thalassemia. N Engl J Med. 1987;316:1050–1055
  12. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in patients with thalassemia. N Engl J Med. 1990;322:417–421
  13. Olivieri NF, Nathan DG, MacMillan JH, et al. Survival in medically treated patients with homogygous beta-thalassemia. N Engl J Med. 1994;331:574–578
  14. Cunningham MJ, Macklin EA, Neueld EJ, Cohen AR. Thalassemia Clinical Research Network. Complications of beta –thalassemia major in North America. Blood. 2002;99:36–43
  15. Witherspoon RP, Fisher LD, Schoch G, et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med. 1989;321(12):784–789
  16. Socié G, Henry-Amar M, Cosset JM, Devergie A, Girinsky T, Gluckman E. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood. 1991;78:277–279
  17. Parkman R, Rappeport J, Geha R, et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone-marrow transplantation. N Engl J Med. 1978;298:921–927
  18. Kapoor N, Kirkpatrick D, Oleske J, et al. Reconstitution of normal megakaryocytopoiesis and immunologic functions in Wiskott-Aldrich syndrome by marrow transplantation following myeloablation and immunosuppression with busulfan and cyclophosphamide. Blood. 1981;57:692–696
  19. Thomas ED, Buckner CD, Storb R, et al. Aplastic anaemia treated by marrow transplantation. Lancet. 1972;i:284–289
  20. Storb R, Champlin RE. Bone marrow transplantation for severe aplastic anemia. Bone Marrow Transplant. 1991;8:69–72
  21. Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med. 1983;309:1347–1353
  22. Tutschka PJ, Elfenbein GJ, Sensenbrenner LL, et al. Preparative regimens for marrow transplantation in acute leukemia and aplastic anemia. Baltimore experience. Am J Ped Hematol Oncol. 1980;2:363–370
  23. Storb R, Thomas ED, Buckner CD, et al. Marrow transplantation in thirty ‘untransfused’ patients with severe aplastic anemia. Ann Intern Med. 1980;92:30–36
  24. Storb R, Prentice RL, Thomas ED, et al. Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol. 1983;55:573–585
  25. Bearman SI, Appelbaum FR, Buckner CD, et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol. 1988;6:1562–1568
  26. Bearman SI, Appelbaum FR, Back A, et al. Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol. 1989;7:1288–1294
  27. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in thalassemia. Hematol Oncol Clin North Am. 1991;5(3):549–556
  28. Lucarelli G, Galimberti M, Polchi P, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med. 1993;329:840–844
  29. Lucarelli G, Clift R, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in Class 3 patients. Blood. 1996;87:2082–2088
  30. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Reviews. 2002;16:81–85
  31. Sodani P, Gaziev J, Polchi P, et al. New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 years. Blood. 2004;104:1201–1203
  32. Lucarelli G, Galimberti M, Polchi P, et al. Bone marrow transplantation in adult thalassemia. Blood. 1992;80:1603–1607
  33. Lucarelli G, Clift RA, Galimberti M, et al. Bone marrow transplantation in adult thalassemic patients. Blood. 1999;93:1164–1167
  34. Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G. Bone marrow transplantation in adults with thalassemia. Treatment and long-term follow-up. Ann NY Acad Sci. 2005;1054:196–205
  35. Di Bartolomeo P, Santarone S, Di Bartolomeo, et al. Long-term results of bone marrow transplantation for thalassemia major in Pescara. Blood. 2004;104:3332
  36. Argiolu F, Sanna MA, Cossu F, et al. Bone marrow transplant in thalassemia. The experience of Cagliari. Bone Marrow Transplant. 1997;19(Suppl. 2):65–67
  37. Clift RA, Johnson FL. Marrow transplants for thalassemia. The USA experience. Bone Marrow Transplant. 1997;19(Suppl. 2):57–59
  38. Lawson SE, Roberts IAG, Amrolia P, Dokal I, Szydlo R, Darbyshire PJ. Bone marrow transplantation for β-thalassemia major: the UK experience in two paediatric centers. Brit J Haematol. 2003;120:289–295
  39. Ghavamzadeh A, Bahar B, Djahani M, Kokabandeh A, Shahriari A. Bone marrow transplantation of thalassemia, the experience in Tehran (Iran). Bone Marrow Transplant. 1997;19(Suppl. 2):71–73
  40. Dennison D, Srivastava A, Chandy M. Bone marrow transplantation for thalassaemia in India. Bone Marrow Transplant. 1997;19(Suppl. 2):70
  41. Lin HP, Chan LL, Lam SK, Ariffin W, Menaka N, Looi LM. Bone marrow transplantation for thalassemia. The experience from Malaysia. Bone Marrow Transplant. 1997;19(Suppl. 2):74–77
  42. Li CK, Shing MK, Chik KW, Lee V, Leung TF, Cheung AYK, et al. Haematopoietic stem cell transplantation for thalassaemia major in Hong Kong: prognostic factors and outcome. Bone Marrow Transplant. 2002;29:101–105
  43. Issaragrisil S, Suvatte V, Visuthisakchai S, et al. Bone marrow and cord blood stem cell transplantation for thalassemia in Thailand. Bone Marrow Transplant. 1997;19(Suppl. 2):54–56
  44. Hongeng S, Pakakasama S, Chuansumrit A, et al. Outcomes of transplantation with related and unrelated-donor stem cells in children with severe thalassemia. Biol Blood Marrow Transplant. 2006;12:683–687
  45. Gaziev D, Galimberti M, Lucarelli G, et al. Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA nonidentical sibling or parent transplants. Bone Marrow Transplant. 2000;25(8):815–821
  46. La Nasa G, Giardini C, Argiolu F, et al. Unrelated donor bone marrow transplantation for thalassemia: the effect of extended haplotypes. Blood. 2002;99(12):4350–4356
  47. La Nasa G, Caocci G, Argiolu F, et al. Unrelated donor stem cell transplantation in adult patients with thalassemia. Bone Marrow Transplant. 2005;36:971–975
  48. Wagner JE, Barker JN, DeFor TE, Bker KS, Blazar BR, Edie C. Transplantation of unrelated donor unblical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100:1611–1618
  49. Jaing T-H, Tan P, Rosenthal J, et al. Unrelated cord blood transplantation (CBT) for thalassemia. Blood. 2006;108:11
  50. Gaziev D, Polchi P, Lucarelli G, et al. Second marrow transplants for graft failure in patients with thalassemia. Bone Marrow Transplant. 1999;24:1299–1306
  51. Gaziev J, Giardini C, Polchi P, Sodani P, Lucarelli G. New approaches to the second transplant for thalassemia. Bone Marrow Transplant. 2004;33(Suppl. 1):S153
  52. Gaziev D, Polchi P, Galimberti M, et al. Graft-versus-host disease after bone marrow transplantation for thalassemia: an analysis of incidence and risk factors. Transplantation. 1997;63:854–860
  53. Andreani M, Manna M, Lucarelli G, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood. 1996;87:3494–3499
  54. Andreani M, Nesci S, Lucarelli G, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after marrow transplantation. Bone Marrow Transplant. 2000;25:401–404
  55. Giardini C, Visani G, Lucesole M, et al. Unusual late rejection of the first graft seven years after allogeneic transplant for thalassemia successfully treated with second BMT. Bone Marrow Transplant. 2007;39(Suppl. 1):S191
  56. Walters M, Ptience M, Leisenring W, et al. Multicenter investigation of bone marrow transplantation for sickle cell disease. Stabel mixed haematopoietic chimerism after bone marrow transplantation for sickle cell anemia. Biol Blood Marrow Transplant. 2001;7:665–673
  57. Iannone R, Casella JF, Fuchs EJ, et al. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant. 2003;9:519–528
  58. Jacobson DA, Duerst R, Tse W, Kletzel M. Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in children. Lancet. 2004;364:156–1662
  59. Lucarelli G, Angelucci E, Giardini C, et al. Fate of iron stores in thalassemia after bone marrow transplantation. Lancet. 1993;342:1388–1391
  60. Angelucci E, Muretto P, Nicolucci A, et al. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis inthalassemia following bone marrow transplantation. Blood. 2002;100:17–21
  61. Angelucci E, Muretto P, Lucarelli G, et al. Phlebotomy to reduce iron overload in patients cured of thalassemia by bone marrow transplantation. Italian Cooperative Group for Phlebotomy Treatment of Transplanted Thalassemia Patients. Blood. 2002;90(3):994–998
  62. Angelucci E, Muretto P, Lucarelli G, et al. Treatment of iron overload in the ‘ex-thalassemic’. Report from the phlebotomy program. Ann NY Acad Sci. 1998;30(850):288–293
  63. Giardini C, Galimberti M, Lucarelli G, et al. : Desferrioxamine therapy accelerates clearance of iron deposits after bone marrow transplantation for thalassemia. Br J Haematol. 1995;89:868–873
  64. Mariotti E, Angelucci E, Agostini A, Baronciani D, Sgarbi E, Lucarelli G. Evaluation of cardiac status in iron-loaded thalassemia patients following bone marrow transplantation: improvement in cardiac function during reduction in body iron burden. Br J Haematol. 1998;103(4):916–921
  65. Gaziev D, Galimberti M, Giardini C, Baronciani D, Lucarelli G. Growth in children after bone marrow transplantation for thalassemia. Bone Marrow Transplant. 1993;12(Suppl.1):100–101
  66. De Sanctis V, Galimberti M, Lucarelli G, et al. Growth and development in ex-thalassemic patients. Bone Marrow Transplant. 1997;19(Suppl. 2):126–127
  67. Strader DB, Wright T, Thomas DL, Seef LB. Diagnosis, management, and treatment of hepatitis C. Hepatology. 2004;39(4):1147–1171

PII: S0268-960X(07)00067-7

doi: 10.1016/j.blre.2007.10.001

Blood Reviews
Volume 22, Issue 2 , Pages 53-63 , March 2008

Article Tools

* Image Usage & Resolution